No significant difference in PIK3CA mutation rate was observed between NECC (4 of 15 tumors [27%]) and either SCC (41 of 158 tumors [26%], P = 1) or ACC (9 of 26 tumors [35%], P = .73). The gene discussed is PIK3CA; the disease is adrenal cortex carcinoma.